PHILADELPHIA (February 8, 2017) – The Fox Chase-Temple University Hospital Bone Marrow Transplant Program has received internationally-recognized accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT) at the University of Nebraska Medical Center for adult allogeneic and autologous hematopoietic progenitor cell transplantation, peripheral blood cellular therapy product collection, and cellular therapy product processing with minimal manipulation. 

PHILADELPHIA (February 2, 2017) – Eric D. Tetzlaff, MHS, a physician assistant at Fox Chase Cancer Center, has been recognized as a Distinguished Fellow of the American Academy of Physician Assistants (AAPA) for his outstanding contributions to patient care and the profession. 

PHILADELPHIA (December 19, 2016) – Fox Chase Cancer Center has received a four-star rating from the Centers for Medicare and Medicaid Services (CMS) in its latest Hospital Care report.

PHILADELPHIA (December 12, 2016) – The Commission on Cancer (CoC), a quality  program of the American College of Surgeons (ACS) has granted Three-Year Accreditation with Commendation to Fox Chase Cancer Center. Three-Year Accreditation with Commendation is only awarded to a facility that exceeds standard requirements at the time of its triennial survey. 

Watch the Region 3 Summit from Wednesday, June 29, 2016, or see the agenda and speakers.